Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $231,642 - $288,006
-300 Reduced 37.5%
500 $442,000
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $579,896 - $727,232
800 New
800 $724,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $6.2 Million - $7.31 Million
11,800 New
11,800 $6.88 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $4.07 Million - $5.44 Million
11,600 New
11,600 $5.44 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $1.16 Million - $1.35 Million
3,600 Added 327.27%
4,700 $1.72 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $326,128 - $371,657
1,100 New
1,100 $356,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $2.71 Million - $2.95 Million
25,400 Added 222.81%
36,800 $4.12 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $1.21 Million - $1.35 Million
11,400 New
11,400 $1.32 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $2.91 Million - $3.34 Million
-38,500 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $4.27 Million - $5.04 Million
-57,500 Reduced 59.9%
38,500 $2.98 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $3.85 Million - $4.13 Million
47,000 Added 95.92%
96,000 $8.11 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $3.78 Million - $4.19 Million
49,000
49,000 $4.19 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.